| Drug Name: | Oxcarbazepine (28721-07-5) |
|---|---|
| PubChem ID: | 34312 |
| SMILES: | C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N |
| InchiKey: | CTRLABGOLIVAIY-UHFFFAOYSA-N |
| Therapeutic Category: | Anticonvulsants, Cardiovascular Agents, Central Nervous System Agents, Cytochrome P-450 CYP3A Inducers, Membrane Transport Modulators, Sodium Channel Blockers, Voltage-Gated Sodium Channel Blockers |
| Molecular Weight (dalton) | : | 252.273 |
| LogP | : | 2.6422 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 63.4 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category